Surgepays is trading at $0.18 (+6.20%), with no new company-specific announcement or reliable catalyst identified for August 25, 2026.
- Recent volatility followed the August 19 filing, which disclosed $1.95 million in cash, a $21.3 million working-capital deficit, and going-concern concerns.
- Broader markets are modestly higher, but the advance does not clearly explain the stock’s move.